Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833.

Inhibition of intestinal P-glycoprotein might enhance the absorption of orally administered P-glycoprotein substrate drugs. We show here a 10-fold increased oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833. These results encourage further research on the...

Descripción completa

Detalles Bibliográficos
Autores principales: van Asperen, J., van Tellingen, O., Sparreboom, A., Schinkel, A. H., Borst, P., Nooijen, W. J., Beijnen, J. H.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228133/
https://www.ncbi.nlm.nih.gov/pubmed/9365166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228133/
https://www.ncbi.nlm.nih.gov/pubmed/9365166

Ejemplares similares